Drug Type Small molecule drug |
Synonyms BIOS 0625, BIOS0625 |
Target |
Action modulators |
Mechanism RIPK1 modulators(Receptor-interacting serine/threonine-protein kinase 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colitis, Ulcerative | IND Approval | China | 10 Nov 2025 | |
| Arthritis | Preclinical | China | 23 Apr 2024 | |
| Neoplasms | Preclinical | China | 23 Apr 2024 | |
| Psoriasis | Preclinical | China | 23 Apr 2024 |





